Post by Cytiva

Advanced therapies are moving fast – but the systems that prepare people to develop and manufacture them often aren’t keeping pace.​ In the latest Global Biopharma Index, our data shows growing pressure around how expertise is developed across areas like cell and gene therapy, mRNA, advanced bioprocessing, and digital manufacturing – not just in R&D, but across the full lifecycle.​ In this article, Anne-Cécile Potmans explores why closer collaboration between academia, industry, and government is becoming critical – and how shared access to technology, training, and real-world environments can help translate scientific potential into scalable impact.​ From university partnerships to open-access innovation centers, it’s a practical look at how the industry can broaden pathways into advanced therapeutics – and make deep expertise more accessible, earlier.👉 Read the article: https://okt.to/lK9ck4 #democratizingadvancedtherapeutics #biomanufacturing #advancedtherapies #biopharma #collaboration

Video Content